Accelerating Medicines Partnership: Alzheimer’s Disease (AMP-AD) Knowledge Portal Aids Alzheimer’s Drug Discovery through Open Data Sharing
Authors:
- 7 February 2016
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 20 (4) , 389-391
Abstract
Accelerating Medicines Partnership-Alzheimer’s Disease (AMP-AD) Knowledge Portal Aids Alzheimer’s Drug Discovery Through Open Data Sharing. . . doi: 10.1517/14728222.2016.1135132Keywords
This publication has 11 references indexed in Scilit:
- Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other lociNature Neuroscience, 2014
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failuresAlzheimer's Research & Therapy, 2014
- The A4 Study: Stopping AD Before Symptoms Begin?Science Translational Medicine, 2014
- Biomarker Modeling of Alzheimer’s DiseaseNeuron, 2013
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseNature Genetics, 2013
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s DiseaseCell, 2013
- NIA Commentary: Translational Issues in Alzheimer’s Disease Drug DevelopmentNeuropsychopharmacology, 2011
- Alzheimers Disease: Pathological Mechanisms and Recent InsightsCurrent Neuropharmacology, 2011
- Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Alzheimer's disease translational research programs at the National Institute on AgingAlzheimer's & Dementia, 2009
- Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventionsAlzheimer's & Dementia, 2007